IN2014MN01382A - - Google Patents
Info
- Publication number
- IN2014MN01382A IN2014MN01382A IN1382MUN2014A IN2014MN01382A IN 2014MN01382 A IN2014MN01382 A IN 2014MN01382A IN 1382MUN2014 A IN1382MUN2014 A IN 1382MUN2014A IN 2014MN01382 A IN2014MN01382 A IN 2014MN01382A
- Authority
- IN
- India
- Prior art keywords
- simethicone
- mannitol
- relates
- calcium phosphate
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/2036—Silicones; Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11193452 | 2011-12-14 | ||
| PCT/NL2012/050879 WO2013095111A1 (en) | 2011-12-14 | 2012-12-11 | Simethicone formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01382A true IN2014MN01382A (pt) | 2015-04-17 |
Family
ID=47628413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1382MUN2014 IN2014MN01382A (pt) | 2011-12-14 | 2012-12-11 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20150119422A1 (pt) |
| EP (1) | EP2790676B1 (pt) |
| AU (1) | AU2012327176B2 (pt) |
| BR (1) | BR112014014278A2 (pt) |
| CA (1) | CA2858821A1 (pt) |
| IN (1) | IN2014MN01382A (pt) |
| RU (1) | RU2602745C2 (pt) |
| WO (1) | WO2013095111A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41620A (fr) | 2015-05-14 | 2018-01-09 | Abdi Ibrahim Ilac Sanayi Ve Ticaret A S | Composition pharmaceutique comprenant de la siméthicone et de l'otilonium |
| EP3294269A1 (en) * | 2015-06-12 | 2018-03-21 | Santa Farma Ilaç Sanayi A.S. | Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics |
| MX2016016587A (es) * | 2016-12-14 | 2018-06-13 | Rhein Siegfried Sa De Cv | Composicion mejorada de lansoprazol y simeticona y procesos para prepararla. |
| CN116159032A (zh) * | 2023-03-31 | 2023-05-26 | 成都恒瑞制药有限公司 | 盐酸西替利嗪片及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4396604A (en) * | 1982-05-17 | 1983-08-02 | Norcliff Thayer, Inc. | Simethicone antacid lozenge |
| US6103260A (en) * | 1997-07-17 | 2000-08-15 | Mcneil-Ppc, Inc. | Simethicone/anhydrous calcium phosphate compositions |
| US6793934B1 (en) | 1999-12-08 | 2004-09-21 | Shire Laboratories, Inc. | Solid oral dosage form |
| US7101573B2 (en) | 2001-09-28 | 2006-09-05 | Mcneil-Pcc, Inc. | Simethicone solid oral dosage form |
| WO2007057924A1 (en) | 2005-11-21 | 2007-05-24 | Panacea Biotec Ltd | Laxative composition on the basis of triphala |
| WO2008056200A1 (en) * | 2006-11-10 | 2008-05-15 | Ranbaxy Laboratories Limited | Oral pharmaceutical compositions of simethicone |
-
2012
- 2012-12-11 BR BR112014014278A patent/BR112014014278A2/pt active Search and Examination
- 2012-12-11 IN IN1382MUN2014 patent/IN2014MN01382A/en unknown
- 2012-12-11 RU RU2014128604/15A patent/RU2602745C2/ru not_active IP Right Cessation
- 2012-12-11 WO PCT/NL2012/050879 patent/WO2013095111A1/en active Application Filing
- 2012-12-11 CA CA 2858821 patent/CA2858821A1/en not_active Abandoned
- 2012-12-11 AU AU2012327176A patent/AU2012327176B2/en not_active Ceased
- 2012-12-11 EP EP12819146.7A patent/EP2790676B1/en not_active Not-in-force
- 2012-12-11 US US14/365,058 patent/US20150119422A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2602745C2 (ru) | 2016-11-20 |
| RU2014128604A (ru) | 2016-02-10 |
| US20150119422A1 (en) | 2015-04-30 |
| AU2012327176A1 (en) | 2013-07-04 |
| EP2790676A1 (en) | 2014-10-22 |
| WO2013095111A1 (en) | 2013-06-27 |
| EP2790676B1 (en) | 2018-01-10 |
| CA2858821A1 (en) | 2013-06-27 |
| AU2012327176B2 (en) | 2015-08-13 |
| BR112014014278A2 (pt) | 2017-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20180102A1 (ar) | مركب صيدلاني | |
| TR201813877T4 (tr) | Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler. | |
| EP2569330A4 (en) | CHLOROTOXINE VARIANTS, CONJUGATES, AND METHODS OF USE THEREOF | |
| IN2012DN06714A (pt) | ||
| MA34058B1 (fr) | Formes de rifaximine, et leurs utilisations | |
| PH12014501273A1 (en) | Intranasal dexmedetomidine compositions and methods of use thereof | |
| IL227626A0 (en) | A compound of 17-il and γ-ifn inhibitors, preparations containing them and their uses | |
| JO3154B1 (ar) | عوامل مضادة لـ trpv4 | |
| JO3755B1 (ar) | تركيبات تستوستيرون | |
| BR112014025041B8 (pt) | Composição farmacêutica | |
| MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
| IN2014DN11078A (pt) | ||
| IN2014MN01382A (pt) | ||
| MY165088A (en) | Pharmaceutical compositions comprising alisporivir | |
| IN2015DN03132A (pt) | ||
| MX2014008390A (es) | Formulaciones de romidepsina y sus usos. | |
| MX2023003000A (es) | Formulaciones de liberacion modificada de viloxacina. | |
| UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину | |
| MX2014006201A (es) | Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse. | |
| MX2013000539A (es) | Nuevas formulaciones de analogos 14-epi de la vitamina d. | |
| TR201002878A2 (tr) | Sefpodoksim proksetil içeren farmasötik bileşimler. | |
| TR200909785A1 (tr) | Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar. | |
| MX363558B (es) | Composiciones farmaceuticas que comprenden flurbiprofeno. | |
| MX2013008559A (es) | Derivados de leptina. | |
| TN2014000484A1 (en) | Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis. |